CANNPAL ANIMAL THERAPEUTICS LIMITED - Announcements

0.00%

17.0¢

Currently unlisted. Proposed listing date: TBA

CannPal Animal Therapeutics Limited is an Australia-based pet pharmaceutical company. The... CannPal Animal Therapeutics Limited is an Australia-based pet pharmaceutical company. The Company is focused on research, developing and commercializing therapeutics for the companion animal health industry, using the compounds derived from the cannabis plants. It is focused on cats and dogs. Its lead drug candidate is CPAT-01, which targets osteosarcoma pain in dogs. It is also engaged in investigating and researching the ability to use cannabidiol derived from the hemp plant for developing a nutraceutical range of products for use in companion animals, including dogs, cats, birds, horses and other domestic animals, without a prescription. It is also developing pharmaceutical therapeutics for chronic pain and appetite stimulation. It is developing nutraceutical products for skin conditions, joint health and digestive health.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CP1	Appendix 3B		08/12/17	95.99KB	Share
CP1	CannPal Receives Import Consent from APVMA	PRICE SENSITIVE	07/12/17	473.05KB	Share
CP1	CannPal Granted Licence to Import from the ODC	PRICE SENSITIVE	22/11/17	84.83KB	Share
CP1	CannPal Appoints Head of Clinical Development and R&D		10/11/17	186.48KB	Share
CP1	CannPal Authorisation to Possess & Supply Medical Cannabis	PRICE SENSITIVE	01/11/17	85.31KB	Share
CP1	Appendix 4C - Quarterly 30 September 2017	PRICE SENSITIVE	31/10/17	186.66KB	Share
CP1	CannPal enters Research Agreement with Queensland University	PRICE SENSITIVE	30/10/17	338.68KB	Share
CP1	Substantial holder notice		27/10/17	352.94KB	Share
CP1	Substantial holder notice		27/10/17	594.09KB	Share
CP1	Substantial holder notice		25/10/17	71.39KB	Share
CP1	Substantial holder notice		25/10/17	155.06KB	Share
CP1	Initial Director's Interest Notice K Adams		25/10/17	94.5KB	Share
CP1	Initial Director's Interest Notice R Clifford		25/10/17	97.89KB	Share
CP1	Initial Director's Interest Notice L Mills		25/10/17	98.79KB	Share
CP1	Initial Director's Interest Notice RM Johnston		25/10/17	94.95KB	Share
CP1	Initial Director's Interest Notice G Starr		25/10/17	94.33KB	Share
CP1	CP1 Ethics Approval	PRICE SENSITIVE	25/10/17	86.22KB	Share
CP1	CP1 ASX Listing Announcement		25/10/17	84.93KB	Share
CP1	Statement of Confirmations		23/10/17	136.75KB	Share
CP1	Corporate Governance Statement		23/10/17	191.22KB	Share
CP1	Securities Trading Policy		23/10/17	79.83KB	Share
CP1	Employee Incentive Option Plan		23/10/17	400.61KB	Share
CP1	Intellectual Property Report		23/10/17	299.74KB	Share
CP1	Audited accounts for year ended 30 June 2017		23/10/17	1.14MB	Share
CP1	Constitution		23/10/17	473.21KB	Share
CP1	Prospectus		23/10/17	1.66MB	Share
CP1	Appendix 1A and Information Form & Checklist		23/10/17	1.68MB	Share
CP1	Top 20 Holders		23/10/17	19.87KB	Share
CP1	Distribution Schedule		23/10/17	28.73KB	Share
CP1	Pre-quotation Disclosure		23/10/17	104.46KB	Share
CP1	ASX Notice		23/10/17	103.23KB	Share
CP1	Admission to Official Quotation	PRICE SENSITIVE	23/10/17	90.48KB	Share

CP1 Appendix 3B
08/12/17		95.99KB	Share
CP1 CannPal Receives Import Consent from APVMA
07/12/17	PRICE SENSITIVE	473.05KB	Share
CP1 CannPal Granted Licence to Import from the ODC
22/11/17	PRICE SENSITIVE	84.83KB	Share
CP1 CannPal Appoints Head of Clinical Development and R&D
10/11/17		186.48KB	Share
CP1 CannPal Authorisation to Possess & Supply Medical Cannabis
01/11/17	PRICE SENSITIVE	85.31KB	Share
CP1 Appendix 4C - Quarterly 30 September 2017
31/10/17	PRICE SENSITIVE	186.66KB	Share
CP1 CannPal enters Research Agreement with Queensland University
30/10/17	PRICE SENSITIVE	338.68KB	Share
CP1 Substantial holder notice
27/10/17		352.94KB	Share
CP1 Substantial holder notice
27/10/17		594.09KB	Share
CP1 Substantial holder notice
25/10/17		71.39KB	Share
CP1 Substantial holder notice
25/10/17		155.06KB	Share
CP1 Initial Director's Interest Notice K Adams
25/10/17		94.5KB	Share
CP1 Initial Director's Interest Notice R Clifford
25/10/17		97.89KB	Share
CP1 Initial Director's Interest Notice L Mills
25/10/17		98.79KB	Share
CP1 Initial Director's Interest Notice RM Johnston
25/10/17		94.95KB	Share
CP1 Initial Director's Interest Notice G Starr
25/10/17		94.33KB	Share
CP1 CP1 Ethics Approval
25/10/17	PRICE SENSITIVE	86.22KB	Share
CP1 CP1 ASX Listing Announcement
25/10/17		84.93KB	Share
CP1 Statement of Confirmations
23/10/17		136.75KB	Share
CP1 Corporate Governance Statement
23/10/17		191.22KB	Share
CP1 Securities Trading Policy
23/10/17		79.83KB	Share
CP1 Employee Incentive Option Plan
23/10/17		400.61KB	Share
CP1 Intellectual Property Report
23/10/17		299.74KB	Share
CP1 Audited accounts for year ended 30 June 2017
23/10/17		1.14MB	Share
CP1 Constitution
23/10/17		473.21KB	Share
CP1 Prospectus
23/10/17		1.66MB	Share
CP1 Appendix 1A and Information Form & Checklist
23/10/17		1.68MB	Share
CP1 Top 20 Holders
23/10/17		19.87KB	Share
CP1 Distribution Schedule
23/10/17		28.73KB	Share
CP1 Pre-quotation Disclosure
23/10/17		104.46KB	Share
CP1 ASX Notice
23/10/17		103.23KB	Share
CP1 Admission to Official Quotation
23/10/17	PRICE SENSITIVE	90.48KB	Share

REFRESH

First

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

CANNPAL ANIMAL THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available